Christopher Wilfong
Founder at 76bio, Inc.
Profile
Christopher Wilfong was the founder of Kronos Bio, Inc. (founded in 2017) and served as the Chief Operating Officer.
Mr. Wilfong is also the founder of 76Bio, Inc. Mr. Wilfong's current job is as an Operating Partner at Two River Group Holdings LLC since 2005.
Mr. Wilfong completed his undergraduate degree at The Wharton School of the University of Pennsylvania in 2005 and obtained an MBA from MIT Sloan School of Management in 2012.
Christopher Wilfong active positions
| Companies | Position | Start |
|---|---|---|
76bio, Inc.
 76bio, Inc. Pharmaceuticals: MajorHealth Technology 76Bio, Inc. is a private company that aims to develop transformational therapies for patients with life-threatening diseases. The company is based in New York, NY. The company focuses on pioneering the next generation of degradation by design. 76Bio was founded by Joshua A. Kazam, David M. Tanen, Marius Pop, Christopher Wilfong, Ben Stone, Angela Koehler, Arie S. Belldegrun, and K. Dane Wittrup. Christopher Wilfong has been the CEO since incorporation. | Founder | - |
Two River Group Holdings LLC
 Two River Group Holdings LLC Investment ManagersFinance Two River Group Holdings LLC is a venture capital firm founded in 2004 by David M.Tanen, Joshua A.Kazam and Ben Bernstein. The firm is headquartered in New York. | Private Equity Investor | 2005-04-30 |
Former positions of Christopher Wilfong
| Companies | Position | End |
|---|---|---|
| KRONOS BIO, INC. | Founder | - |
Training of Christopher Wilfong
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
| MIT Sloan School of Management | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| KRONOS BIO, INC. | Health Technology |
| Private companies | 2 |
|---|---|
76bio, Inc.
76bio, Inc. Pharmaceuticals: MajorHealth Technology 76Bio, Inc. is a private company that aims to develop transformational therapies for patients with life-threatening diseases. The company is based in New York, NY. The company focuses on pioneering the next generation of degradation by design. 76Bio was founded by Joshua A. Kazam, David M. Tanen, Marius Pop, Christopher Wilfong, Ben Stone, Angela Koehler, Arie S. Belldegrun, and K. Dane Wittrup. Christopher Wilfong has been the CEO since incorporation. | Health Technology |
Two River Group Holdings LLC
Two River Group Holdings LLC Investment ManagersFinance Two River Group Holdings LLC is a venture capital firm founded in 2004 by David M.Tanen, Joshua A.Kazam and Ben Bernstein. The firm is headquartered in New York. | Finance |
- Stock Market
- Insiders
- Christopher Wilfong
